JFG
AZN icon

Jefferies Financial Group’s AstraZeneca AZN Stock Holding History

Jefferies Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,400
Closed -$323K – 1610
2023
Q4 		$323K Hold
2,400
– – ﹤0.01% 1350
2023
Q3 		$325K Buy
+2,400
New +$328K ﹤0.01% 1208

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Jefferies Financial Group's AZN Position: Q1 2026 in Review

Jefferies Financial Group increased its AstraZeneca (AZN) stake by 271% in Q1 2026, buying an estimated $2.08M and bringing the position to 14,788 shares worth $2.88M. The position accounts for 0.02% of the portfolio, ranked #491.

Jefferies Financial Group first reported a position in AZN in Q4 2022 and has held it in 9 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Jefferies Financial Group held 14,788 shares of AstraZeneca worth $2.88M as of Q1 2026.
  • Jefferies Financial Group bought 10,800 AstraZeneca shares in Q1 2026, an estimated $2.08M.
  • AstraZeneca made up 0.02% of Jefferies Financial Group's portfolio in Q1 2026, its #491 holding.
  • Jefferies Financial Group first reported a position in AstraZeneca in Q4 2022 and has held it in 9 quarters since.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.